1. Fishchuk, Liliia, Rossokha, Zoia, Pokhylko, Valeriy, Kovtun, Serhii, Gorovenko, Nataliia. 2022. SFTPB (rs11130866) and NR3C1 (rs41423247) gene variants as potential clinical biomarkers for personalized treatment strategy selection in patients with severe COVID-19 pneumonia. In Respiratory investigation, 61, 103-109. doi:10.1016/j.resinv.2022.10.008. https://pubmed.ncbi.nlm.nih.gov/36460583/
2. Wang, Kun, Huang, Qiubo, Zhao, Guangqiang, Yang, Kaiyun, Huang, Yunchao. 2019. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients. In Journal of cellular biochemistry, 120, 14804-14812. doi:10.1002/jcb.28741. https://pubmed.ncbi.nlm.nih.gov/31016788/
3. Cooney, Ashley L, Wambach, Jennifer A, Sinn, Patrick L, McCray, Paul B. 2022. Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction. In Frontiers in genome editing, 3, 785829. doi:10.3389/fgeed.2021.785829. https://pubmed.ncbi.nlm.nih.gov/35098209/
4. Attarian, Stephanie J, Leibel, Sandra L, Yang, Ping, Cole, F Sessions, Hamvas, Aaron. 2018. Mutations in the thyroid transcription factor gene NKX2-1 result in decreased expression of SFTPB and SFTPC. In Pediatric research, 84, 419-425. doi:10.1038/pr.2018.30. https://pubmed.ncbi.nlm.nih.gov/29538355/
智鼠故事 
